NASDAQ:KRMD

Repro Med Systems Stock Insider Trading

Healthcare > Medical - Instruments & Supplies

Buy KRMD

*Your capital is at risk

$3.92

-0.130 (-3.21%)

At Close: Jun 03, 2026

Repro Med Systems Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 99.01. In total, the insiders bought 4.69M and sold 1.68M KRMD shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	99.01
● Buy	4.69M shares
● Sell	1.68M shares
86% Buy Activity Negligible or No Correlation
Buy Signal High Confidence May 15, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 99.01. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (86% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 17, 2026 Buy	Performance Stock Unit A-Award	Pazdan Christopher Chief Operating Officer	C-Suite Officer	31 226 Value: $133.3K
Mar 17, 2026 Buy	Option to buy Common Stock A-Award	Adams Thomas Edward Chief Financial Officer	C-Suite Officer	58 490 Value: $254.4K
Mar 16, 2026 Sell	Common Stock F-InKind	Tharby Linda M Chief Executive Officer	CEO / President	5 756 Value: $24.6K
Mar 16, 2026 Sell	Common Stock F-InKind	Adams Thomas Edward Chief Financial Officer	C-Suite Officer	2 123 Value: $9K
Mar 16, 2026 Sell	Common Stock F-InKind	Pazdan Christopher Chief Operating Officer	C-Suite Officer	1 628 Value: $7K
Mar 16, 2026 Buy	Common Stock M-Exempt	Pazdan Christopher Chief Operating Officer	C-Suite Officer	5 064 Value: $21.7K
Mar 16, 2026 Buy	Common Stock M-Exempt	Adams Thomas Edward Chief Financial Officer	C-Suite Officer	5 404 Value: $23.2K
Mar 16, 2026 Buy	Common Stock M-Exempt	Tharby Linda M Chief Executive Officer	CEO / President	15 968 Value: $68.5K
Feb 13, 2026 Sell	Common Stock J-Other	Manko Joseph M. Jr.	Director	770 418 Value: $0
Feb 13, 2026 Buy	Common Stock J-Other	Manko Joseph M. Jr.	Director	282 347 Value: $1.32M
Feb 13, 2026 Buy	Common Stock J-Other	Manko Joseph M. Jr.	Director	750 000 Value: $3.50M
Feb 13, 2026 Sell	Common Stock J-Other	Manko Joseph M. Jr.	Director	750 000 Value: $0
Jan 02, 2026 Buy	Option to buy Common Stock A-Award	Schiller Eric Chief Technology Officer	Officer	232 297 Value: $1.32M
Jan 02, 2026 Buy	Common Stock A-Award	Schiller Eric Chief Technology Officer	Officer	76 426 Value: $428.7K
Jan 02, 2026 Buy	Restricted Stock Units A-Award	Adams Thomas Edward Chief Financial Officer	C-Suite Officer	75 000 Value: $420.8K
Jan 02, 2026 Buy	Common Stock A-Award	Matin Shahriar Director	Director	2 581 Value: $15.0K
Jan 02, 2026 Buy	Common Stock A-Award	Cascella Robert Director	Director	2 581 Value: $15.0K
Jan 02, 2026 Buy	Common Stock A-Award	French Donna Director	Director	2 581 Value: $15.0K
Jan 02, 2026 Buy	Common Stock A-Award	Wholihan Edward Director	Director	2 581 Value: $15.0K
Jan 02, 2026 Buy	Common Stock A-Award	Fletcher R John Chairman Of The Board	CEO / President	3 872 Value: $22.5K
Dec 31, 2025 Buy	Common Stock A-Award	Manko Joseph M. Jr.	Director	2 581 Value: $15.0K
Dec 31, 2025 Sell	Common Stock G-Gift	Manko Joseph M. Jr.	Director	17 000 Value: $0
Dec 29, 2025 Buy	Common Stock	Schiller Eric Chief Technology Officer	Officer	0 Value: $0
Nov 26, 2025 Sell	Common Stock J-Other	Manko Joseph M. Jr.	Director	41 000 Value: $0
Oct 16, 2025 Buy	Common Stock A-Award	Tharby Linda M President And CEO	CEO / President	29 463 Value: $120.2K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT REPRO MED SYSTEMS, INC.

KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. It offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company also provides education and training ...

Read Full Profile Here